DMD and sarcoglycanopathy: Furthermore, both reduced expression of sarcoglycans and dystrophin are observed in sarcoglycanopathies and dystrophinopathies (5, 6); this makes it difficult to accurately predict the primary genetic defect among them based on muscle immunoanalysis.